AGL · agilon health, inc.
$97.67
-2.60 (-2.59%)
At close · Jul 24
Market Cap
$1.67B
Shares
16.68M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$5.93B
-2.1%
FY2025
Net Income
-$391.35M
-50.4%
FY2025
Operating Margin
-7.81%
-3pp
FY2025
Operating Cash Flow
-$105.76M
-83.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|---|
| $5.68B – $5.81B | $5.82B | $5.93B | $6.06B | $4.32B | $2.39B | $1.52B | $1.22B | $794.41M | |
| — | $226.81M | $238.54M | $268.91M | $285.76M | $207.79M | $427.5M | $137.29M | $122.83M | |
| — | — | $13.4M | $12.3M | $8M | $5M | $8.2M | $11.4M | $10.7M | |
| — | $28.51M | $28.59M | $24.46M | $20.16M | $13.77M | $14.67M | $14.1M | $41.41M | |
| — | $3.3B | — | — | — | $2.83B | $2.23B | $1.28B | $900.99M | |
| — | $6.26B | $6.4B | $6.35B | $4.55B | $2.49B | $1.89B | — | — | |
| — | -$437.13M | -$463.24M | -$292.13M | -$232.13M | -$105.38M | -$372.24M | -$56.67M | -$106.57M | |
| — | — | -7.81% | -4.82% | -5.38% | -4.41% | -24.47% | -4.65% | -13.42% | |
| — | -$408.62M | -$434.64M | -$267.67M | -$211.97M | -$91.61M | -$357.57M | -$42.57M | -$65.16M | |
| — | $6.94M | $6.64M | $6.18M | $6.66M | $4.48M | $6.15M | $8.14M | $9.07M | |
| — | $74.38M | $67.62M | $34.49M | $27.84M | $13.93M | $2.18M | $2.47M | $955K | |
| — | -$2.77M | -$1.84M | $14.99M | $16.49M | $10.72M | -$6.77M | $514K | -$747K | |
| — | -$372.46M | -$404.1M | -$248.83M | -$194.46M | -$90.67M | -$382.98M | -$62.34M | -$114.69M | |
| — | $1.08M | $1.25M | $1.45M | $791K | $1.64M | $886K | $865K | -$232K | |
| — | -$354.54M | -$391.35M | -$260.15M | -$262.6M | -$106.55M | -$406.49M | -$60.05M | -$282.59M | |
| — | — | -6.6% | -4.29% | -6.08% | -4.46% | -26.72% | -4.93% | -35.57% | |
| — | — | $0 | $50K | -$207K | -$311K | -$300K | $0 | -$152K | |
| — | -$354.61M | -$390.34M | -$257.94M | -$259.33M | -$112.11M | -$406.49M | -$60.05M | — | |
| shares | — | — | 16.56M | 16.44M | 16.36M | 16.33M | 14.92M | 12.94M | 11.79M |
| shares | — | — | 16.56M | 16.44M | 16.36M | 16.33M | 14.92M | 12.94M | 11.79M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2023: $206.7M in buybacks.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
0.27×
Medical Care Facilities median 1.22×
EV/EBIT
—
Medical Care Facilities median 18.60×
P/E (TTM)
—
Medical Care Facilities median 16.92×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Medical Services | $5,921,341,000 | $6,047,715,000 | $4,307,350,000 | $2,384,889,000 | — | — | — |
| Other Operating | $11,235,000 | $12,815,000 | $9,013,000 | $3,331,000 | — | — | — |
| Medical Services Revenue | — | — | — | — | $1,518,322,000 | $1,214,270,000 | $788,566,000 |
| Other Operating Revenue | — | — | — | — | — | $4,063,000 | $5,845,000 |
| Product And Service Other | — | — | — | — | $3,172,000 | — | — |
Key facts
CIK
1831097
CUSIP
00857U206
13F (30d)
20 filings
20 filers
Visit website
Investor relations